Tenapanor Shows Response in IBS-C Within Weeks

A post hoc analysis of three clinical trials shows the drug works within weeks to improve bowel function and abdominal symptoms in people with IBS-C.

Related Keywords

Cleveland Clinic ,Florida ,United States ,Jacksonville ,Canada ,Texas ,Vancouver ,British Columbia ,Brian Lacy ,Anthony Lembo ,American College Of Gastroenterology ,Drug Administration ,Cleveland Clinic Digestive Disease Surgery Institute ,Mayo Clinic ,American College ,Digestive Disease ,Surgery Institute ,Texas Health Science Center ,Irritable Bowel Syndrome Ibs ,Prabdominal ,Abdominal Pain ,Bloating Abdominal ,Clinical Research ,Clinical Trials ,Linical Studies ,Pre Clinical Trial ,Double Blind Study ,Double Blind Studies ,Ingle Blind Study ,Ingle Blind Studies ,Pain Management ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,